mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.03 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.03 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
ABT-263 |
FIMM |
pan-cancer |
AAC |
0.3 |
0.03 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.03 |